Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs

Jennifer H. Lofland, Phaedra T. Johnson, Mike Ingham, Sarah C. Rosemas, John C. White, Lorie Ellis
ISSN / E-ISSN
— / —
DOI
10.2147/ppa.s133222 ↗
Volume · Issue · Pages
Volume 11 · — · 947-958
Publisher
Dove Medical Press Ltd.
Article URL
https://doi.org/10.2147/ppa.s133222 ↗
Article details
Unverified
Publication date (each date has its type and source)
01 May 2017
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date01 May 2017 OpenAlex

Keywords (as given): shared decision-making; biologic therapy; autoimmune disease; inflammatory bowel disease; rheumatoid arthritis; psoriatic arthritis; medication adherence; treatment persistence; patient satisfaction; patient activation; health care costs; medication possession ratio; comorbidities; patient-physician communication; treatment initiation; patient-reported outcomes; Patient Activation Measure; Morisky Medication Adherence Scale

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Patient Preference and Adherence
Publication date used
01 May 2017 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.